These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10522754)

  • 1. Plasma and brain levels of oxindole in experimental chronic hepatic encephalopathy: effects of systemic ammonium acetate and L-tryptophan.
    Bergqvist PB; Carpenedo R; Apelqvist G; Moroni F; Bengtsson F
    Pharmacol Toxicol; 1999 Sep; 85(3):138-43. PubMed ID: 10522754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective alterations of extracellular brain amino acids in relation to function in experimental portal-systemic encephalopathy: results of an in vivo microdialysis study.
    Rao VL; Audet RM; Butterworth RF
    J Neurochem; 1995 Sep; 65(3):1221-8. PubMed ID: 7643101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxindole, a sedative tryptophan metabolite, accumulates in blood and brain of rats with acute hepatic failure.
    Carpenedo R; Mannaioni G; Moroni F
    J Neurochem; 1998 May; 70(5):1998-2003. PubMed ID: 9572285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Content of quinolinic acid and of other tryptophan metabolites increases in brain regions of rats used as experimental models of hepatic encephalopathy.
    Moroni F; Lombardi G; Carlà V; Pellegrini D; Carassale GL; Cortesini C
    J Neurochem; 1986 Mar; 46(3):869-74. PubMed ID: 2419500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain quinolinic acid in chronic experimental hepatic encephalopathy: effects of an exogenous ammonium acetate challenge.
    Bergqvist PB; Heyes MP; Bugge M; Bengtsson F
    J Neurochem; 1995 Nov; 65(5):2235-40. PubMed ID: 7595512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of ammonia and portal-systemic shunting on brain metabolism, neurotransmission and intracranial hypertension in hyperammonaemia-induced encephalopathy.
    Vogels BA; van Steynen B; Maas MA; Jörning GG; Chamuleau RA
    J Hepatol; 1997 Feb; 26(2):387-95. PubMed ID: 9059962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated brain 5-hydroxytryptophol levels in experimental portal-systemic encephalopathy.
    Bergqvist PB; Some M; Apelqvist G; Helander A; Bengtsson F
    Pharmacol Toxicol; 1997 Apr; 80(4):187-90. PubMed ID: 9140138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute effects of L-tryptophan on brain extracellular 5-HT and 5-HIAA levels in chronic experimental portal-systemic encephalopathy.
    Bergqvist PB; Hjorth S; Apelqvist G; Bengtsson F
    Metab Brain Dis; 1996 Sep; 11(3):269-78. PubMed ID: 8869946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study of the ameliorating effects of an enteral nutrient for liver failure on hepatic encephalopathy: effects of SF-1008C on plasma and brain free amino acids, intracerebral amine concentrations and electroencephalogram in portacaval shunted rats with ammonia loading].
    Kido Y; Sugiyama K; Nakao S; Kashiyama E; Suda T; Miyamoto G; Shimizu T; Shintani S; Kohri H
    Nihon Yakurigaku Zasshi; 1986 Jul; 88(1):47-56. PubMed ID: 3093339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrasplenic hepatocellular transplantation corrects hepatic encephalopathy in portacaval-shunted rats.
    Ribeiro J; Nordlinger B; Ballet F; Cynober L; Coudray-Lucas C; Baudrimont M; Legendre C; Delelo R; Panis Y
    Hepatology; 1992 Jan; 15(1):12-8. PubMed ID: 1727787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain extracellular quinolinic acid in chronic experimental hepatic encephalopathy as assessed by in vivo microdialysis: acute effects of L-tryptophan.
    Bergqvist PB; Heyes MP; Apelqvist G; Butterworth RF; Bengtsson F
    Neuropsychopharmacology; 1996 Oct; 15(4):382-9. PubMed ID: 8887992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ammonium acetate challenge in experimental chronic hepatic encephalopathy induces a transient increase of brain 5-HT release in vivo.
    Bergqvist PB; Hjorth S; Audet RM; Apelqvist G; Bengtsson F; Butterworth RF
    Eur Neuropsychopharmacol; 1996 Nov; 6(4):317-22. PubMed ID: 8985716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effect of L-carnitine in ammonia-precipitated encephalopathy in the portacaval shunted rat.
    Therrien G; Rose C; Butterworth J; Butterworth RF
    Hepatology; 1997 Mar; 25(3):551-6. PubMed ID: 9049197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of reducing brain glutamine synthesis on metabolic symptoms of hepatic encephalopathy.
    Hawkins RA; Jessy J; Mans AM; De Joseph MR
    J Neurochem; 1993 Mar; 60(3):1000-6. PubMed ID: 8436955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutamine metabolism and neuropathological disorders in experimental hepatic encephalopathy: effect of transplanted hepatocytes.
    Mariani P; Coudray-Lucas C; Baudrimont M; Ribeiro J; Legendre C; Delelo R; Cynober L; Balladur P; Nordlinger B
    Surgery; 1996 Jul; 120(1):93-9. PubMed ID: 8693429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic inhibition of brain protein synthesis after portacaval shunting. A possible pathogenic mechanism in chronic hepatic encephalopathy in the rat.
    Wasterlain CG; Lockwood AH; Conn M
    Neurology; 1978 Mar; 28(3):233-8. PubMed ID: 564477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the oral administration of branched chain amino acids on hepatic encephalopathy in the rat.
    Beaubernard C; Delorme ML; Opolon P; Boschat M; Morin J; Oryszcyn MP; Franco D
    Hepatology; 1984; 4(2):288-94. PubMed ID: 6200419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased blood-brain transport of tryptophan after portacaval anastomoses in germ-free rats.
    Jeppsson B; James JH; Hummel RP; Brenner W; West R; Fischer JE
    Metabolism; 1983 Jan; 32(1):4-8. PubMed ID: 6848895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tryptophan metabolism and hepatic encephalopathy. Studies on the sedative properties of oxindole.
    Mannaioni G; Carpenedo R; Corradetti R; Carlà V; Venturini I; Baraldi M; Zeneroli ML; Moroni F
    Adv Exp Med Biol; 1999; 467():155-67. PubMed ID: 10721052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between plasma free fatty acids and experimentally induced hepatic encephalopathy in the rat.
    Smit JJ; Bosman DK; Jörning GG; de Haan JG; Maas MA; Chamuleau RA
    Clin Chim Acta; 1991 Mar; 197(2):95-104. PubMed ID: 2049860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.